(Q45877059)

17 December 2017

title

Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL. (English)

1 reference

17 December 2017

1 reference

Harui A

1

1 reference

17 December 2017

Roth MD

2

1 reference

17 December 2017

Kiertscher SM

3

1 reference

17 December 2017

Mitani K

4

1 reference

17 December 2017

Basak SK

5

1 reference

17 December 2017

publication date

1 November 2004

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

22

1 reference

17 December 2017

page(s)

1617-1626

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302332

exact match

0 references

cites work

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Helper-dependent adenoviral vector-mediated gene transfer in aged rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Dendritic cell activation induced by various stimuli, e.g. exposure to microorganisms, their products, cytokines, and simple chemicals as well as adhesion to extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Development and maturation of secondary lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Murine dendritic cells infected with adenovirus vectors show signs of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Dendritic cell survival and maturation are regulated by different signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Replication and packaging of helper-dependent adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

Update on adenovirus and its vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Improved performance of a fully gutted adenovirus vector containing two full-length dystrophin cDNAs regulated by a strong promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Worldwide epidemiology of human adenovirus infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Cross-priming is under control of the relB gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer--changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Simple chemicals can induce maturation and apoptosis of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Effect of adenovirus gene transfer vectors on the immunologic functions of mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302332

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302332

1 reference

17 December 2017

Dimensions Publication ID

1029047785

0 references

Fatcat ID

release_6jpie4a2gbdufflz6tzcphae7a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6jpie4a2gbdufflz6tzcphae7a

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017